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The B-adrenerglc receptor kinase mediates agomst-dependent phosphorylatlon of /&adrenerglc receptors, which 1s thought to represent he first 
step of homologous desensitization. We have expressed bovine and human BARK1 in St9 cells and purified them to apparent homogeneity m 
milligram quantities. The &-values of the enzyme were 3.8 PM for rhodopsin and 22 PM for ATP: the r’,,,,, -value was 9.9 mol phosphate/m01 
BARK/mm. These data indicate that the two recombinant kmases were at least as active as preparations previously obtained from bovme brain 
There were no differences in the functional activity of human and bovine BARK. 
B-Adrenergic receptor kinase; &4drenergic receptor; Rhodopsin; Receptor phosphorylatlon; Baculovlrus; Spodopkvz frugzprrda cell 
1. INTRODUCTION 
Signal transduction by G protein-coupled receptors 
is subject to regulation by a multitude of mechanisms, 
and one of the most prominent of these is a process 
called desensitization. Desensitization is defined as a 
decline of receptor-mediated effects in response to con- 
tinuous or repeated agonist exposure. This process has 
been studied most extensively for the &adrenergic re- 
ceptor/G,/adenylylcyclase system [ 1,2]. /I-Adrenergic re- 
ceptors can become desensitized via phosphorylation by 
protein kinase A or the /3-adrenergic receptor kinase 
@ARK) [l-3]. Phosphorylation of the receptors by 
PARK, followed by binding of the inhibitor protein 
B-arrestin to the phosphorylated receptors [3-61 repre- 
sents the most rapid and quantitatively most important 
mechanism causing agonist-induced, homologous de- 
sensitization of p-adrenergic receptors [7]. In addition 
to phosphorylating Pz-adrenergic receptors, PARK can 
also phosphorylate ol,-adrenergic and muscarinic recep- 
tors as well as the ‘light receptor’ rhodopsin [g-lo]. 
PARK phosphorylates (and thereby desensitizes) only 
receptors which are occupied by agonists apparently for 
two reasons. First, only the agonist-occupied receptors 
are good substrates for BARK and, therefore, agonist- 
occupancy of receptors and BARK-dependent phos- 
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A BarnHI site was created m the cDNA for bovine BARK1 [3] 
immediately 5’ to the start codon by ligating into the Bali site two 
complementary ohgonucleotides (47 and 51 nucleotides) correspond- 
ing to the BARK1 sequence. The 2.1 kbp BanzHI-NheI fragment 
contaimng the whole coding region of/?ARK was introduced mto the 
BanzHI-XbuI hnearized baculovirus vector pVLl393 [16] to generate 
the transfer vector pVL-bov/?ARKl for the expression of bovine 
BARK1 under the control of the polyhedrin promoter. 
Abbreviaf~ons. BARK, B-adrenergic receptor kinase: CM. carbox- Cloning of the humanBARK cDNA was performed essentially as 
ymethyl: DEAE, diethyl aminoethyl; MOI, multiplicity of infection described for bovine BARKl. A 2.8 kbp EcoRI fragment coding for 
(plaque forming units/cell); PCR, polymerase chain reactlon; SDS- human BARK1 [17], provided by Dr. J. Benovic, was complemented 
PAGE. sodium dodecyl sulfate-polyacrylamide gel electrophoresls. with a PCR product from A431 cell cDNA to reconstitute the 5’-end 
phorylation occur in parallel [6,11]. Second, the cy- 
tosolic BARK appears to require G protein /3y-sub- 
units, presumably liberated upon G protein activation 
by receptors, in order to bind to the membranes in close 
vicinity to the receptors [12-141. 
The cDNAs of two isoforms of PARK have been 
cloned to date, of which PARK1 appears to be the 
major isoform responsible for phosphorylating p2- 
adrenergic receptors, since it is more widely distributed 
and more active towards &receptors than PARK2 [15]. 
Previous studies on BARK have been done mostly with 
preparations partially purified from bovine brain, or 
with cytosolic extracts from transiently transfected 
COS-cells. These preparations were neither purified to 
homogeneity nor, in the case of the most commonly 
used bovine brain preparations, defined in their isoform 
composition. and were limited in quantity. In order to 
overcome these problems we undertook the expression 
of the bovine and human major isoform PARK1 using 
the baculovirus expression system [ 161. 
2. MATERIALS AND METHODS 
2.1. Plasnud constructions 
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ofBARK. A 1.0 kbp SacI fragment located withm theBARK coding 
region was replaced by a second PCR product from human A43 1 cell 
cDNA to correct mutations m the clone. The resultmg cDNA se- 
quence was shown to be identical with that published by Chuang et 
al. [18] and was cloned into pVLl393 to yield pVL-ht$ARKl. 
2.2. Productwn of recombmant bacuhrrus und rzpre.wor~ ofpARK in 
.y9 cells 
Recombinant baculovnuses were produced by co-transfectlon of 
Spodoptera fruglperdu Sf9 cells. with 200 ng of the transfer vector and 
20 ng of baculovirus DNA contaming a lethal deletion (BaculoGold. 
Dianova). Single recombinant plaques were isolated from the pool of 
recombinant viruses and amplified m Sf9 cells. A large batch of recom- 
binant viruses was obtamed after three rounds of amphfication 
(MO1 = 0.1). For large scale expression, Sf9 cells were grown m sus- 
pension (200 ml) and Infected at a cell density of 2 x 10h/ml 
(MO1 = 10). Cells were harvested after 3 days and washed three times 
in PBS. 
2.3. Punjicatlon of PARK 
The cell pellets were resuspended m lys~s buffer (25 mM Tris-HCI. 
pH 7.5, 5 mM EDTA, 5 mM EGTA. 100 PM PMSF. 10 pug/ml 
leupeptin and 10 &ml benzamidine: 10 ml/pellet of a 200 ml suspen- 
sion culture). The cells were disrupted with an ultraturraw six times for 
30 s at 4°C and centrtfuged for 30 mm at 250,000 x g. NaCl(l0 mM) 
was added to the supernatant which was then adsorbed to DEAE- 
Sephacel (Pharmacia-LKB, 1 ml/5 ml supernatant) for 30 min at 4°C. 
The slurry was poured mto a column. and the pass-through plus a 15 
ml wash with lys~s buffer contammg 10 mM NaCl were collected. 
These fractions from the DEAE-Sephacel column were diluted 4-fold 
with IO mM Tris-HCl, pH 7.4, 2 mM EDTA, 0.02% Triton X-100 and 
apphed onto a 8 ml CM-Fractogel (Merck) column. The column was 
washed with 50 ml of 10 mM Tris-HCl, pH 7.4.2 mM EDTA, 0.02% 
Triton X-100. and eluted stepwise with the same buffer containing 20 
to 100 mM NaCl. All column fractions were analyzed by SDS-poly- 
acrylamide gel electrophoresis and were assayed for /IARK activity 
using rod outer segments as substrate. The concentration of purified 
PARK was measured using the protein determination method of 
Bradford [19] 
2.4. PARK assy, 
Activity of BARK was measured as described earher [11,20] using 
urea-treated rod outer segments as substrate. Standard condmons 
were mcubattons for 10 min at 30°C m 20 mM Tris-HCI. pH 7.5. 8 
mM MgC12, 2 mM EDTA, and 100 PM []I-“PJATP (0.42 cpm/fmol) 
Unless otherwise indicated. substrate concentrations were 0.6 PM for 
rhodopsin, or 10 nM humanD,-adrenergic receptor, the latter purified 
from St9 cells (Hekman et al.. m preparation) and co-reconstituted 
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Fig. 1. Purification of bovIneBARK from Infected Sl9 cells. Aliquots of non-infected Sl9 cells (panel A. lane 1). or cells infected with recombinant 
baculovirus (lane 2), of the cytosol from infected cells (lane 3). of the DEAE-Sephacel pass-through of the cytosol (lane 4) and of the fractions 
eluting from the CM-Fractogel column at 20, 30. 40. 50. 60. 70. 80 and 100 mM NaCl (panel B, lanes l-8) were subjected to SDS-PAGE, and 
proteins were visualized by Coomassie blue stainmg. The ,!?ARK-activities of the CM-Fractogel fractions shown in panel B (lanes l-8) were 
determmed by measuring rhodopsin phosphorylation (panel C. lanes l-8). 
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with 50 nM G protein~~-subunits purified from bovine brain 1211. For 
determination of K, and V,,, of the enzymes for the receptor sub- 
strates, the cofactor [Y-~‘P]ATP was used at a saturating concentratton 
of 300 PM. Purified BARK was present at 3 nM unless otherwise 
indicated. At the end of the utcubation. the phosphorylat~ substrates 
were resolved by SDS-PAGE and identified by autoradlography. 
[3’P]Phosphate incorporation was measured by excision of the sub- 
strate bands and determination of their “P content. 
3. RESULTS 
Infection of Sf9 cells with recombinant baculovirus 
coding for either bovine or human BARK1 resulted in 
a time-dependent expression of BARK as revealed by 
determination ofpARK-activity, or by SDS-PAGE and 
Coomassie stains. Maximal expression was obtained 3 
days after infection with a MO1 of 10 (not shown). 
Under these conditions, BARK was seen in Coomassie- 
stained gels as the major soluble protein in infected Sf9 
cells (Fig. 1). 
Bovine BARK was purified from the cytosol of these 
cells by a simplified procedure adapted from the proto- 
col used for the purification of PARK from bovine 
brain [22]. The particulate fraction was removed by 
centrifugation. and the supernatant was applied at low 
ionic strength onto a DEAE-Sephacel anion exchange 
column. All PARK activity was recovered in the pass 
through fractions from this column (not shown). @ARK 
was by far the major protein in these eluates (Fig. 1). 
Subsequent chromatography of the DEAE-eluates on a 
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Fig. 2. ATP-dependence of the activity of purified recombinant 
PARK. Rod outer segments (0.6 PM rhodopsin) were incubated for 
5 min at 30°C under bright light with purified bovine #?ARK (6 nM) 
and 3.5200 ,ffM [Y-~‘P]ATP (== 0.2 cpmlfmol). The rod outer seg- 
ments were pelleted at 4°C and subjected to 12.5% SDS-PAGE “P- 
labeled rhodopsin was visualized by autoradiography (inset) and the 
“P-content determmed by ~erenkov-coun~lng of the excised bands. 
Non-linear curve-fitting [23] yielded values for K,,, = 22 + 5 PM and 
V tn.,Y = 1.72 ?c 0.14 mol phosphate/m01 BARIUmin. 
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Fig. 3. Concentration-dependent phosphorylation of rhodopsin by 
purified recombinant BARK. Rod outer segments (0.2-20 ,&I rho- 
dopsin) were phosphorylated for 5 min at 30°C under bright light with 
bovine PARK (3 nM). ATP was used at a saturating concentration of 
300pM. Non-lmear curve-fittmg [23] yielded values for K,,, = 3.8 rt 0.7 
,uM and V,,,,, = 9.9 F 0.8 mol phosphate/m01 BARWmin. 
CM-Fractogel cation exchange column resulted in puri- 
fication of PARK to apparent homogeneity. The 
amounts of PARK in the eluates determined by SDS- 
PAGE were exactly paralleled by BARK-activity (Fig. 
1, panels B and C). The yields of purified kinase were 
about 1-2 mg (- 12-24 nmol) per 200 ml suspension 
culture. 
The catalytic properties of the recombinant kinases 
were investigated by determination of their K,,,- and 
I/,,,-values for rhodopsin, and for ATP. The studies 
were performed with rhodopsin (in the form of rod 
outer segments) as substrate, both because it is more 
readily available than /$receptors. and because it has 
been shown that the V,,,-values of the brain enzyme for 
rhodopsin and &-receptor were identical [22]. In the 
presence of 0.6 ,uM rhodopsin, the apparent Km of puri- 
fied recombinant bovine PARK for the cofactor ATP 
was 22 i 5 FM, and the apparent V,,, was 1.72 + 0.14 
mol phosphatelmol PARKlmin (Fig. 2). This Km-value 
for ATP is similar to the value of 33-37 PM of the 
kinase purified from bovine brain [22]. 
At a satu~dting concentration of ATP (300 PM), the 
K,,, for rhodopsin was 3.8 + 0.7 PM and the V,,, was 
9.9 ? 0.8 mol phosphate/m01 PARKlmin (Fig. 3), val- 
ues which are similar to those reported for the bovine 
brain enzyme of 6 ,uM and 5.X mol phosphate/m01 
PARIUmin, respectively [22]. 
The purification of human BARK was achieved in an 
identical manner. No differences in the elution profiles 
from anion or cation exchanger columns were detecta- 
ble. The kinetic constants of the recombinant human 
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Table I 
Phosphorylation of humanBz-adrenergic receptor by bovine or human 
BARK 
BARK (nM) 
3.7 
37.0 
mol P,/mol P,-adrenergic receptor 
Bovine PARK Human PARK 
2.0 * 0.02 2.5 2 0 02 
3.7 * 0.2 4.7 * 0.2 
BARK were identical to those of the bovine enzyme 
with respect to the substrate rhodopsin or the cofactor 
ATP (not shown). 
Phosphorylation of /3,-adrenergic receptors by either 
bovine or human PARK was assayed after co-reconsti- 
tution with G protein py-subunits, which have been 
reported to be required for full activity of BARK to- 
wards receptors [12-141. In contrast to earlier data [22], 
we did not observe any significant phosphorylation of 
&receptors in the absence of py-subunits (not shown). 
Maximal phosphorylation stoichiometries for P,-recep- 
tors in the presence of By-subunits were up to 5 mol 
phosphate/m01 receptor (Table I). Bovine and human 
BARK displayed only minor differences in their activity 
with respect to the human receptor as a substrate. 
4. DISCUSSION 
Our data indicate that PARK can be expressed and 
purified in substantial quantities using the baculovirus 
system. The kinases purified from Sf9 cells appear to be 
fully functional. This is indicated by affinities for ATP 
and rhodopsin, and V,,, -values, that compare favoura- 
bly with those of the enzyme prepared from bovine 
brain. In fact, the V,,,- values for the bovine brain prep- 
aration. which were extrapolated from preparations of 
10% purity [22], were about 2-fold lower than those 
obtained with the recombinant enzyme. This difference 
may be due to difficulties in the extrapolation, or to 
protein degradation during the lengthy purification pro- 
cedure. In any case, the data suggest that the recombi- 
nant proteins have essentially the same activity and the 
same properties as the native protein. 
PARK purified from bovine brain [22] was the first 
kinase preparation available for the study of agonist- 
specific phosphorylation of the ,&adrenergic receptor. 
In addition to the characterization of recombinant bo- 
vine BARK we analysed whether human PARK differs 
from bovine BARK in its specific activity towards its 
natural substrate, the human P,-adrenergic receptor. 
Bovine and human /3ARK show 98% protein sequence 
identity [ 171 and no significant differences of their activ- 
ities were detected using either rhodopsin or the pZ- 
adrenergic receptor as substrates (Table 1). Thus the 
amino acid exchanges do not appear to be functionally 
relevant with respect to the functional properties of the 
recombinant kinases. However, in order to develop in- 
62 
hibitors ofPARK, the availability of the human enzyme 
is clearly an advantage, since the problem of species- 
differences of such inhibitors can be avoided. 
In summary, expression of /3ARK in Sf9 cells permits 
the purification of large quantities of the kinase to ap- 
parent homogeneity which will help in the elucidation 
of the mechanisms and physiological functions of this 
key enzyme in the control of signalling by B-adrenergic 
and probably many other G protein-coupled receptors. 
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